Table 1. Correlation between EIF5A2 expression and clinicopathological features of primary ESCC.
| Clinicopathological features | All cases | EIF5A2 expression | P value | |
|---|---|---|---|---|
| − | + | |||
| Gender | 0.924 | |||
| female | 13 | 7 (53.8%) | 6 (46.2%) | |
| male | 76 | 42 (55.3%) | 34 (44.7%) | |
| Age | 0.221 | |||
| < 57 year | 53 | 32 (60.4%) | 21 (39.6%) | |
| ≥ 57 year | 36 | 17 (47.2%) | 19 (52.8%) | |
| Differentiation | 0.184 | |||
| 1–2 | 62 | 37 (59.7%) | 25 (40.3%) | |
| 3 | 27 | 12 (44.4%) | 15 (55.6%) | |
| T status | 0.119 | |||
| T1-T2 | 15 | 11 (73.3%) | 4 (26.7%) | |
| T3-T4 | 74 | 38 (51.4%) | 36 (48.6%) | |
| N status | 0.011 | |||
| N0 | 20 | 16 (80.0%) | 4 (20.0%) | |
| N1 | 69 | 33 (47.8%) | 36 (52.2%) | |
Note: The Pearson Chi-Square test was used as statistical analysis. Significant difference was defined when P < 0.05.